跳至主要内容
临床试验/NL-OMON47120
NL-OMON47120已完成4 期

iposomal amphotericin B (Ambisome) pharmacokinetics given as a single intravenous dose to obese patients (ASPEN). - ASPE

Radboud Universitair Medisch Centrum0 个研究点目标入组 16 人开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
入组人数
16

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • 1. Patient has a BMI *40 kg/m2 and is undergoing bariatric surgery.
  • 2. Subject is at least 18 years of age on the day of screening.
  • 3. Subject or legal representatives are able and willing to sign the Informed Consent before screening evaluations.

排除标准

  • 1. Documented history of sensitivity to medicinal products or excipients similar to polyene antifungal agents.
  • 2. History of, or current abuse of drugs, alcohol or solvents (up until a maximum of three months before enrolment).
  • 3. Inability to understand the nature of the trial and the procedures required.
  • 4. Administration of nephrotoxic medication (aminoglycosids, immunosuppressants, antivirals, antineoplastic agents) up until a maximum of one month before enrolment.

研究者

相似试验

进行中(未招募)
1 期
Pharmacokinetics of liposomal amphotericin B (Ambisome) in obese patients.Prophylaxis for patients at risk for invasive fungal infection due to gastric bypass surgery.MedDRA version: 17.1Level: PTClassification code 10017533Term: Fungal infectionSystem Organ Class: 10021881 - Infections and infestations
EUCTR2014-003306-33-NLRadboud university medical center16
已完成
4 期
Liposomal Amphotericin B (AmBisome) Pharmacokinetics Given as a Single Intravenous Dose to Obese Patients (ASPEN)Morbid Obesity
NCT02320604Radboud University Medical Center16
进行中(未招募)
2 期
iposomal amphotericin B for the treatment of Bangladeshi patients with visceral leishmaniasis.
ACTRN12609001029280The United Nations Children's Fund (UNICEF)/ The United Nations Development Programme (UNDP) /World Bank /World Health Organization (WHO) Special Programme for Research and Training in Tropical Diseases (TDR)35
招募中
不适用
Empirical treatment of liposomal amphotericin B for febrile neutropenia. that persists despite broad-spectrum antibacterial therapyfebrile neutropenia
JPRN-UMIN000005163The first department of internal medicine, University of Fukui50
已完成
2 期
iposomal amphotericin B for the treatment of Nepalese patients with visceral leishmaniasis.Visceral LeishmaniasisInfection - Other infectious diseases
ACTRN12610000130066The United Nations Children's Fund (UNICEF)/ The United Nations Development Programme (UNDP) /World Bank /World Health Organization (WHO) Special Programme for Research and Training in Tropical Diseases (TDR)35